Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $37.13 (-0.8%) * Over Last 12-Mos
Rating Score: 2.8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/7/2015 Barclays New Coverage Overweight
(N/A)
50.00
(N/A)
33.98 37.42 10.12% Details
12/19/2014 Wells Fargo New Coverage Market Perform
(N/A)
36.00
(N/A)
35.57 37.42 5.2% Details
Like MYGN Ratings? Also take a look at TSRO, ABBV, AZN

MYGN Ratings News